BNET Industries
Last Fiscal Year Sales:$124.6M
- Public
- US
Dow Jones Description
The Company manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases. Bentley's drug delivery technology is focused on improving the delivery of pharmaceuticals and peptides through a broad range of proprietary drug delivery technologies.
Chairman and Chief Executive Officer of Rjm Group
F. Ross JohnsonNumber of Employees 470
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
bentley pharmaceuticals inc. - All News and Analysis
Generic Drugs: Industry Snapshot
Mike Havrilla submits:Global Generic Drug Industry: Benchmark Comps Global Generic Drug Industry: Top 5 Companies by Market Cap Global Generic Drugs: Top 5 Companies by Stock Performance The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity --...
Bentley Pharmaceuticals Notifies NYSE of Intention to Delist Common Stock
EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE: BNT) ("Bentley" or the "Company") announced today that it notified the New York Stock Exchange (the "NYSE") of its intent to delist its common stock, par value $0.02 per share, from the NYSE immediately following the consummation of the transactions contemplated by the...
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
EXETER, N.H. -- Bentley Pharmaceuticals, Inc. ("Bentley") (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva") has been adjusted in accordance with the merger agreement after completion of the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc....
Bentley Board Approves Spin-off of Drug Delivery Business
Bentley Sets July 22, 2008 as Date for Stockholders to Vote on Proposed Acquisition by Teva Pharmaceutical Industries Ltd. EXETER, N.H. -- The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business into a new publicly traded company to be...
Bentley Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instruction Your first question comes from Randall Stanicky of Goldman Sachs. Randall Stanicky - Goldman Sachs Hey, guys. Thanks a lot for the question and again congratulations on getting the deal with Teva in place. I just have one question and John I was hoping...
Bentley Pharmaceuticals Announces First Quarter Financial Results
Reports Revenues of $40.0 Million in the First Quarter; Revenues Increase 27% over 2007 First Quarter EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the first quarter and three months ended March 31, 2008. First quarter 2008 revenues...
Teva to Acquire Bentley Pharmaceuticals
Acquisition Will Provide Teva with a Strong Platform to Become a Leading Player in Spain JERUSALEM & EXETER, N.H. -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which Teva will acquire Bentley. The...
Bentley Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Thank you. Operator Instructions. Your first question is from David Merris with Balyasny. Please go ahead. David Merris Good morning guys. Question on the strategic options on the generic business without going in to any details, I am sure you wouldn’t – what’s...
Auxilium Pharmaceuticals, Inc. and Bentley Pharmaceuticals, Inc. Announce Issuance of Patent Covering Testim(R)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) today announced that the United States Patent and Trademark Office ("USPTO") has issued U.S. Patent No. 7,320,968 covering Testim®, 1% testosterone gel, marketed by Auxilium under license from Bentley. The patent will expire in January 2025. ...
Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 Presenter Profiles
MONTE CARLO, Monaco -- Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo. For in-depth information about the event visit http://www.rodmanandrenshaw.com/Conferences.asp?CID=conf9. Below are profiles from Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 presenters; breaking news releases are available at...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Lane Bassett Hunt | President |
| Jim Buckley | Executive Vice President |
| Elaine Melia | Director, Finance |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| F. Ross Johnson | Chairman and Chief Executive Officer of Rjm Group |
| Michael McGovern | Vice Chairman and Director |
| Edward J. Robinson | Chairman |
| John W. Spiegel | Chairman of the Nominating and Governance Committee |
| Miguel Fernandez | Chairman of the Compensation Committee |
| Adolfo Herrera | Board of Directors |
| Charles L Bolling | Board of Directors |
| Johm W. Spiegel | Board of Directors |
F. Ross Johnson has been the Chairman and Chief Executive Officer of RJM Group, a management advisory and investment firm, since 1989. Prior to 1989, Mr. Johnson was the President and Chief Executive Officer of RJR/Nabisco, Inc., an international consumer products company, having held various senior executive positions in RJR/Nabisco, Inc. and its predecessors, Standard Brands and Nabisco Brands since 1971. He received a Bachelor of Commerce from the University of Manitoba, Canada and a Master of Commerce from the University of Toronto, Canada. Mr. Johnson serves on the boards of directors of AuthentiDate Holding Corporation and EdgeStone Capital Partners and serves on the advisory boards of Power Corporation of Canada, Wachovia Bank Florida, Bennett Advisory Group Palm Beach and Black & McDonald Ltd.
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Chairman and Chief Executive Officer of Rjm Group | Current |
| Black & McDonald | Board of Directors | Current |
| EdgeStone Capital Partners Inc. | Board of Directors | Current |
| AuthentiDate Holding Corp. | Chair of Board | Former |
| University of Toronto | Master of Commerce | Former |
| University of Manitoba | Bachelor of Commerce | Former |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | President | Current |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Director, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Vice Chairman and Director | Current |
| Employment Technologies Corp | Vice Chairman of the Board | Current |
| Bentley Pharmaceuticals, Inc. | Board of Directors | Former |
| University of Illinois | Juris Doctor | Former |
| University of Illinois | M.S. In Accounting | Former |
| University of Illinois | B.S. | Former |
Edward J. Robinson has served as one of our directors since 2004. Mr. Robinson served as Chief Operating Officer of Meditrust Operating Company, a healthcare REIT, in 1998. Previously he was the President and Chief Operating Officer of Avon Products, Inc., a public beauty products company, from 1993 to 1997, and Executive Vice President and Chief Financial Officer of Avon Products, Inc. from 1989 to 1992. Prior thereto, he held various positions with RJR Nabisco and its predecessor companies, Standard Brands and Nabisco Brands, including Executive Vice President, Chief Financial Officer, Vice President Treasurer and Senior Vice President Controller. Mr. Robinson servers on the board of directors of Medical Staffing Network Holdings, Inc. and also serves on the Advisory Board of W.R. Capital Management L.P. He received a B.A. in Business Administration from Iona College. Mr. Robinson is a Certified Public Accountant licensed by the State of New York. Mr. Robinson has been retired since 1998.
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Chairman | Current |
| Medical Staffing Network Holdings Inc. | Board of Directors | Current |
| Avon Products, Inc. | President | Former |
| Avon Products, Inc. | Executive Vice President and Chief Financial Officer | Former |
| Kraft Foods Inc. | Executive Vice President | Former |
| Iona College | B.A. In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| World Trade Center of Atlanta | Current | |
| Bentley Pharmaceuticals, Inc. | Chairman of the Nominating and Governance Committee | Current |
| Credisphere | Chairman of the Board | Current |
| Rock-Tenn Company | Chairman | Current |
| S1 Corporation | Non-Executive Chairman | Current |
| Children's Healthcare | Board of Directors | Current |
| Colonial Properties | Board Member | Current |
| HomeBanc Corp. | Board of Directors | Current |
| Colonial Properties Trust | Board of Directors | Current |
| Bank Administration Institute | Board of Directors | Current |
| The Advisory Council | Board of Directors | Current |
| HBMC Holdings LLC | Board of Directors | Current |
| Creative Growth Group, Inc. | Board of Directors | Current |
| Fsb Solutions | Board of Directors | Current |
| S1 Enterprise | Board of Directors | Current |
| The Advisory Council | Member | Current |
| Children's Healthcare | Trustee | Current |
| SunTrust Banks, Inc. | Chief Financial Officer | Former |
| Bentley Pharmaceuticals, Inc. | Vice Chairman and Chief Financial Officer of Suntrust Banks, Inc. | Former |
| SunTrust Banks, Inc. | Executive Vice President | Former |
| High Museum of Art | Former | |
| Bank Administration Institute | Chairman | Former |
| Rock-Tenn Company | Board of Directors | Former |
| SunTrust Banks, Inc. | Director | Former |
| SunTrust Banks, Inc. | Vice Chairman | Former |
| Emory University | MBA | Former |
| Wabash College | Bachelor's Degree In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Chairman of the Compensation Committee | Current |
| GlaxoSmithKline Plc | Vice President for Latin America | Former |
| The University of Western Ontario | M.B.A. | Former |
| University of British Columbia | Former |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Board of Directors | Current |
| Bentley Pharmaceuticals, Inc. | Managing Director | Current |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bentley Pharmaceuticals, Inc. | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes


